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Summltflt'y 
Collagen-induced arthritis (CIA) is an animal model of autoimmune inflammatory polyarthritis 
that has features similar to rheumatoid arthritis  (RA). Much like RA, susceptibility to mouse 
CIA is influenced by the major histocompatibility complex (MHC), H-2, and restricted to the 
H-2q and H-2 r haplotypes.  Whereas  the role of the H-2A molecule in  susceptibility to CIA 
is well established, little is known about the role of H-2E molecule in the disease.  In this study, 
we analyzed the effect of a transgenic  E/3  a molecule on CIA  susceptibility in a recombinant 
mouse B10.RQB3,  which expresses the CIA  susceptible Aq genes and an Ea  k gene, but does 
not produce an E molecule since Ebq is nonfunctional.  In the presence of an Eb  a transgene,  a 
viable E molecule is generated. Whereas B10.RQB3 were susceptible to CIA, B10.RQB3-E~ d+ 
showed a dramatic reduction in the incidence of arthritis  as well as a decrease in the level of 
anti-mouse and anti-bovine CII antibodies in their serum. No clear cut differences in the expression 
of  T  cell  receptor  (TCR)  V~/  was  observed  between  EB  d+  and  E~  d-  transgenic  mice. 
Mechanisms underlying the protective effect of E~  d transgenic molecule on CIA may shed light 
on how HLA-DR molecules influence human  RA. 
T 
ype II collagen (CII) is a sequestered molecule found 
in joint cartilage (1). Rodents can be induced to generate 
an autoimmune inflammatory polyarthritis  (CIA) by injec- 
tion of heterologous CII (2). Susceptibility to arthritis in mice 
is restricted  to  the  MHC  haplotypes  H-2q and  H-2  r  (3). 
Using recombinant strains,  susceptibility in the H-2q haplo- 
type has been narrowed down to the class II molecule en- 
coded by H-2A loci (4). 
Four genes encode the mouse class II molecules; Aa and 
Ab genes encode for the heavy (H) and light  (L) chains of 
the A  molecule respectively whereas Ea and Eb encode for 
the H  and L chains of the E molecule (5). The A molecule 
is expressed in all mouse haplotypes studied, whereas the E 
molecule is not (6). Four haplotypes of inbred mouse strains, 
b, s, q, and f, as well as 19 of 33 mouse strains carrying wild- 
type MHC haplotypes are E negative.  Mice of the f and q 
haplotypes fail to synthesize both Eol and E~ chains.  Mice 
of the b and s haplotypes fail to produce Eo~ chains but do 
express EB molecules which remain in the cytoplasm as par- 
tially glycosilated precursors  (7). 
While the critical role of A molecule in the susceptibility 
to CIA has been stressed (8), little is known about the role 
of E molecule in the disease. The human MHC genes (HLA) 
are also known to play a critical role in the susceptibility to 
rheumatoid arthritis (RA) (9). The human class II molecule 
HLA-DK, which is homologous to mouse H-2E, is clearly 
important for the predisposition to RA (9). Previous studies 
have demonstrated a relationship between severity of RA and 
increasing DR4 or DR1 frequency (10,  11). Recent studies 
have further  located the structural  element  conferring dis- 
ease susceptibility to the third  hypervariable region of the 
DK~I  chain  (12).  To determine  the role of E  molecule in 
CIA, we analyzed CIA susceptibility in transgenic B10.RQB3- 
EB  a mice which expresses the CIA susceptible Aq genes as 
well as a viable E molecule. Our results support a protective 
role of the E/~  d molecule in CIA  susceptibility. 
Materials  and Methods 
Mice.  All the mice used in this study were bred and maintained 
in our pathogen-free  mouse colony and were 8-12 wk of age at 
the start  of the experiment. 
Generation of E~ Transgenic Mice.  A 15.7-kb DNA fragment 
isolated from  a BALB/c cosmid library covering the entire  Eb  a 
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jected into (SWR x  B10.M)F, embryos as described (14). Trans- 
gene positive mice were identified by Southern blot analysis. The 
Eb  d gene  was  introduced  into  the  B10.RQB3 mice by back- 
crossing. Expression of the EB  d molecule was analyzed by flow 
cytometry as described below (15). The transgenic mice used in 
these studies were from the N9-N10 backcross population. 
Flow Cytometry.  Analysis  of EB  a and VB TCR expression on 
PBL were determined by flow cytometry as previously described 
(15). Briefly,  PBL and were isohted by Ficoll separation, washed, 
and then incubated with the E~d-specific mAb 34-1-4S (16) for 
30 rain at 4~  After washing, the cells were incubated with FITC 
goat anti-mouse IgG (Accurate Chemicals and Scientific Corp., 
Westbury, NY) for 30 rain at 4~  washed, and then fixed with 
1% paraformaldehyde  before analysis. Analysis for V/3 TCR was 
done using the following mAbs: B20.6, anti-V~2; KT4-10, anti- 
Vt54; MRg-4,  anti-V~5.1-5.2; 44-22-1. anti-VB6; TR-310, anti- 
V/~7; F23.2, anti-VBS.2; MR10-2, anti-V139; KT11, anti-V~511; and 
14.2, anti-V/~14. Second antibodies consisted of FITC-conjugated 
mouse anti-rat IgG or IgM or goat anti-mouse IgG. T cell subsets 
were identified by incubation with mAbs specific  for mouse CD4 
and CDSa conjugated to R-Phycoerythrin and Red 613, respec- 
tively (GIBCO BILL, Gaithersburg, MD). Single-color (for'E/3  a) 
and three-color (for V/3 TCR) flow cytometric analysis was per- 
formed using a FA~  flow cytometer (Becton Dickinson& 
Co., Mountain View, CA). 
Induction and Quantification of Arthritis.  Bovine  CII (BII), pre- 
pared as previously  described (3), was dissolved  in 0.1 M acetic acid 
at a concentration of 2 mg/ml then emulsified 1:1 with complete 
Frennd's adjuvant H37 Ra (Dffco  Laboratories,  Detroit, MI). Mice 
received 100/~g of cold emulsion intradermally in the base of the 
tail. Mice were monitored three times a week from week 3 to 9 
post immunization for the onset and development of CIA. The 
arthritic severity  of all four limbs was determined as previously  de- 
scribed (3) using a grading system for each paw based on a scale 
of 0-3 as follows: 0 = normal; 1 =  redness and swelling in paws 
or toes; 2 = deformity in paw; and 3 =  ankylosis in the affected 
joint. The clinical score from each limb was summed thus giving 
a severity range of 0-12 per mouse. The mean arthritic severity 
was determined using arthritic animals only. 
Measurement of Serura Anti-CIl Antibody.  Mice  were bled via 
the  taft artery on day 35  post immunization  and the level of 
anti-mouse CII (MII) and anti-BII Abs in serum were determined 
using a standard ELISA technique (17). Sera was tested at 1/100 
and 1/400 dilutions and compared with a pooled positive control 
sera. The data is expressed as mean OD  _+  SD. 
Statistical Analysis.  Arthritis incidence  between groups was ana- 
lyzed using chi-square test with Yates' correction. Antibody levels 
were compared using the Student's t test. 
Results 
Unlike  mice  carrying  the  standard  H-2q  haplotype 
(B10.Q, DBA/1), B10.RQB3 recombinant mice synthesize 
the Eot  k molecule. The introduction of a 15.7-kb DNA frag- 
ment containing the entire Eb gene from the H-2  d haplo- 
type was sufficient to induce the expression  of H-2E mole- 
cules in these mice.  Flow cytometric analysis showed that 
the level of surface expression  of EB  a molecule in the 15.7 
transgene positive (E3  d+) mice was comparable to the ex- 
pression of the same molecule in mice of the H-2  d haplotype 
(Fig.  1). Expression of EBaE~x  d in positive control animals 
(B10.D2)  was 54%  whereas the expression  of EBaEc~  k in 
15.7 EB  d+  B10.RQB3 mice was 52%.  Negligible staining 
(<1%) was detected in EB  a transgene negative (F_d3  d-) lit- 
termates and B10 control (H-2  b) mice. Tissue distribution 
of the Eb transgene was comparable to the endogenous mol- 
ecule in E positive strains of mice (data not shown). 
To investigate the effect of H-2E molecule on the suscepti- 
bility to CIA, B10.RQB3 15.7 E3  d§  and E3  d-  littermates 
were immunized with bovine CII in CFA. At 9 wk postim- 
munization, the incidence of arthritis in  F43  d*  mice was 
significantly lower than in EB  d- littermates (p <0.01, Table 
1). Among the three E3q5.7 + animals that developed CIA, 
the extent of arthritis was mild as indicated by arthritic scores 
from 1 to 2. In contrast, a majority of arthritic E3  a- litter- 
mates displayed severe swelling in at least two limbs, and their 
arthritic scores ranged from 1 to 8. 
The inhibitory effect of the 15.7 Eb  d transgene was also 
apparent in the development of antibody against CII. Anal- 
ysis of sera at a 1/100 dilution showed a 32% reduction in 
mean OD  of BII-reactive Ab mice and a 45%  decrease in 
reactivity against homologous MII Ab in EB  d  § vs. E3  d- lit- 
termates (F <0.001,  Table  1). 
Through flow cytometry, deletion in V~5.1, 5.2,  and 11 
bearing T cell populations was found in both CD4 and CD8 
subsets  for E3  d  + and EB  a-  mice (Table 2).  No significant 
difference in the V3 TCR expression  was evident between 
the two groups with the exception of CD4 +,  V~11 + T 
cells, which were further decreased in E~  d  + mice. The dele- 
tion of VB5 and VB11 T cells was expected in Eb  d transgene 
negative B10.RQB3 mice since they express an interisotypic 
AB/E~ molecule known to delete some TCR V3-bearing 
T  cell populations (18). 
To confirm our observations, we used a second line of 
BIO.D2 (-I) Con[ml  BIO.ROU3-EBd {+~ 
2. 
8m.Roo3-[  (-) 
1 l~-  t L[3  ....  "{'[~ 
Figure  1.  Analysis  of E~  a ex- 
pression using the 34-1-4S mAb 
in B10.RQB3 (Eb  d transgene + 
and -) mice. 
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CIA*  Anti-CII AbS 
Mice  Incidence  Arthritis  severity  BII  MII 
mean +_ SD 
E~ Tg Positive  3/13  1.3  _+  0.6  0.35  _+  0.05  0.12  _+  0.1 
p  <0.001  p  <0.001  p  <0.001 
E~ Tg Negative  16/20  3.8  +  2.0  0.51  +  0.06  0.22  _+  0.08 
* Mice were immunized with 100 #g BII in CFA on day 0 and monitored regularly  for the onset  and development of CIA. 
* Determined at 9 wk post immunization.  The mean severity  of arthritis  was  calculated  using arthritic animals only. 
S Animals  were bled at 5 wk post immunization and the level of antibody against BII and MII determined by an ELISA. Data is presented  as the 
mean OD at a  1:100 dilution. 
Table  2.  Peripheral Expression of Vfl  TCR  in  Transgenic 
BIO.RQB3-E~ Positive and BIO.RQB3-~ Negative  Mice* 
Percentage  of positive T  cells 
E~ positive  E~ negative 
V3  CD4  CD8  CD4  CD8 
mean + SD 
Vfl2  5.2  +  1.0  4.9  _+  1.9  5.1  _+  1.1  3.9  _+  2.4 
Vfl4  6.5  +  0.3  5.5  _+  0.4  7.3  +  0.3  5.8  _+  0.2 
Vfl5.1.2  0.4  _+  0.1  5.1  _+  0.3  1.0  +  0.5  7.4  +  0.5 
Vfl6  7.8  +  1.9  12.6  +  1.3  4.6  +  0.9  13.1  _+  1.3 
Vfl7  2.2  +  0.3  5.9  +  0.1  3.6  -+  1.1  9.4  +_  3.8 
V38.2  14.5  _  0.6  7.4  _+  0.8  16.4  +  0.5  7.1  +  0.6 
V/39  1.9  -+  0.1  5.2  _+  1.8  1.7  .+  0.1  6.3  +  1.6 
VB11  0.6  .+  0.3  1.1  +  0.8  1.9  ,+  1.2  1.9  _+  1.5 
VB14  7.3  _+  0.5  2.9  ,+  0.5  6.9  _-#  0.4  2.4  +  0.2 
* Normal  transgenic  B10.RQB3-E~*  and  B10.RQB3-E~-  mice were 
bled and their PBL stained for V3 TCK expression as detailed in Materi- 
als and  Methods.  The mean percentage  was  calculated  based on four 
animals per group. 
E3  a transgenic mice, E3  a 10.2, generated in our laboratory. 
This  second Eb  d gene  construct  contains  only 200 bp  of 
5'-flanking region. The well defined c/s-regulatory elements 
controlling  class  II gene expression  are containing  in  this 
flanking  region  (6,  19).  The  presence of this  200 bp up- 
stream sequence is sufficient to control expression of the trans- 
gene  similar  to  the  Eb  d  15.7  transgene  and  endogenous 
class II gene (Glimcher, L.H., unpublished data). Flow cyto- 
metric  analysis  also showed that  expression  of E~aEoe  k in 
B10.RQB3-E3 a 10.2 + was comparable to that  observed in 
B10.RQB3-E3 d 15.7 + mice (data not  shown). 
Similar  to B10.RQB3-E3  d 15.7 + mice,  B10.RQB3-E3  d 
10.2 + mice showed a significant reduction in the incidence 
and severity of arthritis  vs. E3 a-  littermates after immuni- 
zation with bovine CII (Table 3). Also, among the four E3  a 
10.2 § mice that developed CIA, the severity of arthritis was 
mild compared to E~  d 10.2- littermates. Finally,  like in E3  d 
15.7 mice, analysis  of sera at a 1/100 dilution in E~  d 10.2 + 
animals showed a 37% reduction in mean OD of BII-reactive 
Ab and a 42% decrease in reactivity against homologous MII 
Ab vs.  E/~  d-  littermates. 
To examine the suppressive effect of E3  d molecules on ar- 
thritis susceptibility in heterozygous mice, the development 
of CIA in (B10.RQB3  x  B10.D2)F1 animals was examined. 
Flow cytometry showed that the level of surface expression 
Table  3.  Protection against CIA  in BIO.RQB3-E~ 10.2  Transgenic Mice" 
CIA*  Anti-CIl AbS 
Mice  Incidence  Arthritis  severity  BII  MII 
mean  +_ SD 
E~ Tg positive  4/14  1.7  _+  1.0  0.22  _+  0.03  0.24  -+  0.1 
p  <0.03  p  <0.01  p  <0.01 
E~ Tg negative  7/11  3.3  _+  1.7  0.35  +  0.08  0.41  _+  0.10 
* Mice were immunized with 100 #g BII in CFA on day 0 and monitored regularly  for the onset and development of CIA. 
* Determined at 9 wk post immunization.  The mean severity  of arthritis  was calculated  using arthritic animals  only. 
$ Animals  were bled at 5 wk post immunization and the level of antibody against BII and MII determined by an ELISA. Data is presented  as the 
mean optical  density  at a  1:100 dilution. 
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CIA* 
Mice  Incidence  Arthritis  severity 
(B10.RQB3  x  B10.D2)~t  6/15s 
B10.KQB3-E~ Tg positive  3/12 II 
B10.RQB3-E~ Tg negative  6/8sll 
mean  +  SD 
2.7  _+  1.5 
2.0  +_  1.0 
3.6  _+  1.0 
* Mice were immunized with 100/zg BII in CFA on day 0 and moni- 
tored regularly for the onset and development of CIA. 
t Determined at 9 wk post immunization. The mean severity of arthri- 
tis was calculated  using arthritis animals only. 
S, p <0.05 
il,  p  <0.01 
of E/3  a  molecule in  (B10.KQB3  x  B10.D2)F1 mice was 
similar  to  B10.RQB3-E/~ a+  and  B10.D2  mice  (data  not 
shown).  The  incidence  of  CIA  was  compared  between 
(B10.KQB3  x  B10.D2)F1 mice and B10.KQB3-E/3 a+  and 
Eft  a-  transgenic  mice.  Like  B10.RQB3-E/~ a+  animals, 
(B10.KQB3  x  B10.D2)F1 mice showed a significant reduc- 
tion in  the incidence of arthritis  versus B10.KQB3-Efl a- 
mice (Table 4). However, in (B10.RQB3  x  B10.D2)F1 mice, 
the decrease of CIA appeared intermediate compared with 
B10.KQB3-E/3 a+ animals (40% vs. 25%). This observation 
shows an inhibitory role of EB  a molecule on CIA coded by 
an endogenous gene as well as a transgene. 
Discussion 
Here we report for the first time the generation of mice 
presenting the unique feature of being H-2Aq positive and 
expressing an H-2E molecule at the same time. As expected, 
B10.KQB3  mice are CIA susceptible because they express 
I-Aq (18). In this strain, E molecules are not expressed since 
EB  q is nonfunctional (7,  8).  By introducing an Eb  a trans- 
gene, we induced expression of E molecules in B10.KQB3 
mice, resulting in a dramatic reduction in the incidence of 
CIA as well as the level of anti-BII and anti-MII Ab in the 
serum of EB  d + transgenic mice. Analysis of V/3 TCR ex- 
pression on PBL demonstrated the deletion of V~5.1, V/35.2, 
and V311 bearing T cells in both Eft  a+ and E/$  a- B10.KQB3 
mice. Although the presence of the E/3  d molecule justifies 
these results in E positive mice (20, 21), it has been demon- 
strated that the Eot/A3 heterodimer expressed in B10.RQB3 
(E/~-) mice plays a similar role to Ec~/Efl dimers in the de- 
letion of several Vfl bearing T  cell populations  (18). 
Previous studies in other mouse models of autoimmune 
diseases have demonstrated that the expression of a functional 
E molecule can play a protective role (22).  By introducing 
an Ea transgene into nonobese diabetic (NOD) mice, the re- 
stored expression of E molecules led to protection against 
insulin-dependent diabetes meUitus (23-25). Also, expression 
of an Ea  d transgene led to a dramatic reduction in the de- 
velopment of autoimmune glomerulonephritis in BXSB mice 
(26). There are several distinct differences between our studies 
and the earlier work in NOD and BXSB mice. First, in the 
aforementioned studies, expression of E molecules was re- 
stored by introduction of a transgene derived for the non- 
polymorphic Ea gene. In our studies in CIA, we restored 
expression of E  molecules using a polymorphic Eb  gene. 
Second, Merino et al.  (26) reported that resistance to glo- 
merulonephritis in E(x  d transgenic BXSB  mice was likely 
due to an exceedingly high copy number (,'o50) of Ea  d trans- 
gene. Southern blot analysis of our two lines of B10.KQB3- 
E3  a transgenic mice, 15.7 and 10.2,  revealed that the copy 
number of Eb  a transgene was ,'o4-8 and 5-10, respectively. 
Finally,  expression of E  molecules in heterozygous H-2  b/d 
BXSB mice did not protect these animals from the develop- 
ment of autoimmune disease (27).  Likewise, Podolin et al. 
(28)  showed that progeny of an (NOD  x  NOD.H-2k)~I 
cross were not protected from the development of diabetes. 
In our studies, we observed that (B10.KQB3  x  B10.D2)F1 
mice showed a significant reduction in the incidence of CIA 
vs. B10.RQB3  animals (Table 4).  Therefore, through both 
tramgenic and conventional genetic techniques, it appears that 
introduction of an Eb  d gene can alter susceptibility to CIA. 
Several nonmutually exclusive  mechanisms may account 
for the protective effect of EB a in CIA. H-2E3 a expression 
could modulate the T cell repertoire by presenting a "tolero- 
genic" peptide which leads to the deletion or regulation of 
arthritogenic T  cell clones. It is also possible  that a Thl to 
Th2 switch occurs in the CII response in the context of the 
E/3  a molecule. It has been shown that the administration of 
the Th2-derived cytokine IL-4 could facilitate remission of 
CIA in DBA/1 (H-2q) mice (29).  Finally,  it is possible  that 
H-2Aq  mediates  the presentation  of EB  peptides  derived 
from the EB  a molecule itself which, in turn, modulates the 
arthritogenic response.  Although studies directed towards 
characterizing naturally processed peptides associated  with 
class II molecules have shown that a portion of peptides bound 
to H-2A molecules are derived from Ec~ chains (30), the con- 
tribution of E3-derived peptides is not clear. Likewise, the 
scope  of  self-peptides  associated  with  H-2Aq  molecules, 
which is of interest in our system, remains to be elucidated. 
Of importance, B10.KIII  (H-2  ~) mice are susceptible to 
CIA despite expression of functional E molecules (31). It is 
possible that, unlike E/3  d, the EB  ~ molecule does not lead to 
protection in  CIA.  Previously, we found that  (B10.Q  x 
B10.K)F1 mice are CIA susceptible,  suggesting that E~  k does 
not play a protective role. Thus, polymorphism of the Eb 
gene, in the context of particular haplotypes, may play a role 
in determining self tolerance or autoimmunity. Indeed, pre- 
liminary studies suggest that the protective effect of the Eft  a 
molecule in CIA is q haplotype specific;  no difference was 
observed in arthritis susceptibility between transgene positive 
and negative offspring of a (B10.KQB3-EB d  x  B10.KIII)Ft 
cross  (our  unpublished  observations).  In  B10.RIII  mice, 
H-2E  r would be functionally equivalent to DR1 and DR4 
subtypes associated in human with KA. Presentation of DRB 
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explain observed differences in the role of DR molecules in 
RA. Variants of the HLA-DR4 family and HLA-DR1 sub- 
types may be deficient in mediating protection, analogous 
to H-2E  r in r  mice. 
In closing, our data is the first demonstration of a protec- 
tive role of E/~ molecules in murine CIA. Experiments are 
currently underway to further delineate the role of H-2E/3 
molecules in CIA and understand the mechanisms involved 
in the protection. These studies will shed light on the pos- 
sible role of DR molecules in human RA. 
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